IntrinsicIntrinsic
← Scroll for more →

Financial Statements — TNON

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Cash & Equivalents1.684.613.763.447.8510.316.549.161.974.392.433.375.853.182.133.157.884.682.92
Short-term Investments------------------------0.491.746.449.388.140.004.40
Accounts Receivable1.951.971.701.310.770.890.860.880.680.570.520.770.600.320.230.140.080.060.08
Inventory0.780.811.051.360.690.610.610.610.610.630.550.470.570.420.420.810.630.600.19
Total Current Assets4.817.626.776.559.8811.998.2111.194.095.953.894.967.935.849.3513.6716.865.437.67
Property, Plant & Equipment0.770.900.920.660.840.700.750.910.900.990.960.960.950.850.790.290.240.220.10
Goodwill2.412.412.412.41------------------------------
Intangible Assets0.460.470.490.50------------------------------
Total Non-current Assets*5.125.223.993.821.231.401.631.851.922.072.462.361.931.791.741.271.271.721.60
Total Assets9.9212.8410.7610.3711.1113.399.8413.046.018.026.357.329.867.6311.0914.9418.137.159.27
Accounts Payable0.630.650.850.630.890.500.371.091.110.270.430.760.910.930.550.420.350.430.48
Total Current Liabilities8.317.413.213.042.562.191.873.183.402.263.143.096.872.752.531.272.2415.4015.27
Total Non-current Liabilities*3.363.542.512.531.841.822.001.671.772.132.431.722.092.402.310.720.780.840.91
Total Liabilities11.6710.945.725.574.404.023.874.855.174.405.574.808.955.164.841.993.0216.2416.18
Retained Earnings(88.83)(84.78)(81.30)(78.47)(75.13)(72.36)(68.75)(65.66)(62.47)(58.65)(55.07)(51.94)(48.61)(44.32)(39.49)(31.59)(28.42)(22.93)(20.57)
Total Stockholder Equity(1.74)1.905.044.806.719.385.978.190.833.620.782.520.902.476.2512.9515.11(22.74)(20.55)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q1 2021
Total Revenue1.281.381.481.170.560.730.770.890.900.720.810.940.740.430.280.210.140.070.02
Cost of Revenue0.470.430.460.400.320.400.420.470.430.250.250.410.550.480.480.300.270.280.01
Gross Profit0.810.951.020.770.250.320.350.420.470.470.560.540.19(0.05)(0.21)(0.09)(0.14)(0.20)0.00
Research & Development0.770.660.530.430.500.690.570.660.710.670.690.740.900.830.810.800.660.560.09
Selling, General & Admin1.531.711.632.201.481.661.891.762.191.931.671.651.731.981.941.732.721.040.10
Total Operating Expenses4.174.223.884.173.104.003.533.634.343.983.703.914.524.847.723.175.321.880.19
Operating Income(3.35)(3.28)(2.87)(3.39)(2.86)(3.68)(3.17)(3.21)(3.87)(3.51)(3.14)(3.38)(4.32)(4.89)(7.93)(3.26)(5.46)(2.08)(0.19)
Interest Expense------------------0.030.020.000.09--------0.270.01
Net Income(4.05)(3.48)(2.83)(3.34)(2.77)(3.62)(3.09)(3.18)(3.83)(3.58)(3.13)(3.33)(4.28)(4.83)(7.90)(3.17)(5.49)(2.35)(0.20)
Basic EPS(12.35)(0.31)2.45(0.40)(0.36)(1.01)(187.60)(3.63)(1.02)(1.25)(222.95)(1.46)(0.33)(0.43)(26.95)(0.28)(0.65)----
Diluted EPS(12.35)0.312.45(0.40)(0.36)(1.01)(187.60)(3.63)(1.02)(1.25)(222.95)(1.46)(0.33)(0.43)(26.95)(0.28)(0.65)----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Operating Cash Flow(2.76)(2.96)(2.22)(3.82)(2.21)(2.48)(2.78)(2.34)(2.42)(2.34)(2.28)(3.15)(3.18)(3.58)(3.38)(3.41)(2.76)(2.46)
Capital Expenditures0.170.060.19(0.11)0.190.12(0.04)0.100.120.12--0.060.130.080.600.080.040.13
Free Cash Flow*(2.93)(3.02)(2.42)(3.71)(2.41)(2.60)(2.74)(2.45)(2.54)(2.46)--(3.21)(3.30)(3.66)(3.99)(3.49)(2.80)(2.59)
Investing Cash Flow(0.17)(0.06)(0.19)(0.64)(0.19)--0.04(0.10)0.00(0.12)(0.09)0.441.134.672.34(1.32)(8.18)4.28
Financing Cash Flow0.003.872.730.06(0.06)6.260.119.640.004.371.370.274.71(0.04)(0.02)0.0014.19(0.05)
← Scroll for more columns →

* Derived from reported values

Dividends Per Share

(USD)
MetricQ3 2023
Dividends Per Share1.00
← Scroll for more columns →